- It simultaneously provides the risks for up to 24 months of: Mortality Ischaemic Stroke or Systemic Embolism Major Bleeding Incl. Haemorrhagic Stroke
- It allows clinicians to compare the effects of different anticoagulant treatment decisions – no oral anticoagulation (no OAC), vitamin K antagonist (VKA), non-vitamin K oral anticoagulant (NOAC) – based on the results from similar patients in the GARFIELD-AF Registry.
- It uses routinely collected clinical data and includes a total of 16 questions.
- It has been derived from the GARFIELD-AF population and externally validated.
Filter Results By:
Select to change risk plot
|Mortality|| Ischaemic Stroke or |
| Major Bleeding Incl. |
| No OAC |